The US IPO market was mixed this week with four successful pricings and an unusually high number of companies withdrawing plans to go public.
Chinese ADRs continued to be well-received...read more
Complete Genomics, which offers outsourced DNA sequencing services to academic/biopharma customers, raised $54 million by offering 6 million shares at $9, below the range of $12-$14. Complete Genomics plans to list on the NASDAQ under the symbol GNOM. UBS...read more
The US IPO market has been highly active so far this month with sixteen completed deals, and this week's flurry of filings indicates it shows no signs of slowing. A total of six companies...read more
Mixed bag for US IPO market this week with four pricings, five withdrawals
The US IPO market was mixed this week with four successful pricings and an unusually high number of companies withdrawing plans to go public. Chinese ADRs continued to be well-received...read more
Complete Genomics prices IPO at $9, below the range
Complete Genomics, which offers outsourced DNA sequencing services to academic/biopharma customers, raised $54 million by offering 6 million shares at $9, below the range of $12-$14. Complete Genomics plans to list on the NASDAQ under the symbol GNOM. UBS...read more
8 IPOs planned for the week of Nov 8
The following IPOs are expected to price this week:
Complete Genomics (GNOM), which offers outsourced DNA sequencing services to academic/biopharma customers, plans to...read more
US IPO market forges ahead with six companies announcing terms so far this week
The US IPO market has been highly active so far this month with sixteen completed deals, and this week's flurry of filings indicates it shows no signs of slowing. A total of six companies...read more